Drs. Vadim Koshkin and Thomas Hope, of the University of California, San Francisco, and Dr. Jérémie Calais, of the University of California, Los Angeles, meet to discuss the recent findings of their clinical investigation, “Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers.”
In Part 2 of this series, the trio highlights whether bone scans overstage disease compared with PSMA PET at initial staging, including a summary of results for bone scans and false positive implications, as well as the larger implications for clinical practice and future clinical trial design in prostate cancer.
View their previous comments on the background of the study.